Eugene Braunwald, Harvard University, Boston
Lowering LDL Cholesterol intensively as a means of treating aortic stenosis was found to have no benefit in the SEAS (Simvastatin and Ezetimibe In Aortic Stenosis) study reported by Terje Pederson at a Hot Line session of the E.S.C. Congress. But the potential gains from such lowering in other clinical situations could be considerable, according to Eugene Braunwald who chaired the session. In Munich they talked with Peter Goodwin.